These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 33197833)
1. Identification and quantification of five impurities in cloperastine hydrochloride. Liu HY; Cheng QZ; Fu HZ; Zhong ZH; Xia HY; Guo YF; Zheng SS; Yu SS J Pharm Biomed Anal; 2021 Jan; 193():113731. PubMed ID: 33197833 [TBL] [Abstract][Full Text] [Related]
2. Development of chromatographic methods for the determination of genotoxic impurities in cloperastine fendizoate. García A; Rupérez FJ; Ceppa F; Pellati F; Barbas C J Pharm Biomed Anal; 2012 Mar; 61():230-6. PubMed ID: 22226040 [TBL] [Abstract][Full Text] [Related]
6. [Separation and identification of impurities from intermediates of istradefylline]. Wang Y; Lü X; Xu H; Meng Z; Li J; Xu Z; Xue M Se Pu; 2021 Apr; 39(4):430-436. PubMed ID: 34227764 [TBL] [Abstract][Full Text] [Related]
7. Isolation, structure characterization and quantification of related impurities in asperosaponin VI. Ji D; Liu YF; Wang QH; Zhang CF; Yang ZL Chin J Nat Med; 2013 Jul; 11(4):419-26. PubMed ID: 23845554 [TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of some potential impurities in ropinirole hydrochloride. Sahasrabuddhey B; Nautiyal R; Acharya H; Khyade S; Luthra PK; Deshpande PB J Pharm Biomed Anal; 2007 Mar; 43(4):1587-93. PubMed ID: 17207602 [TBL] [Abstract][Full Text] [Related]
9. Identification, synthesis, isolation and spectral characterization of potential impurities of montelukast sodium. Saravanan M; Siva Kumari K; Pratap Reddy P; Naidu MN; Moses Babu J; Srivastava AK; Lakshmi Kumar T; Chandra Sekhar BV; Satyanarayana B J Pharm Biomed Anal; 2008 Nov; 48(3):708-15. PubMed ID: 18755563 [TBL] [Abstract][Full Text] [Related]
10. Determination, Isolation, and Identification of Related Impurities in Erdosteine Bulk Drug. Liu H; Xiong X; Wang J; Pei K; Zhong Z; Zhou Z; Cheng Q J AOAC Int; 2022 Apr; 105(3):696-702. PubMed ID: 34677591 [TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of potential impurities of amlodipine maleate. Sudhakar P; Nirmala M; Moses Babu J; Vyas K; Madhusudan Reddy G; Vijaya Bhaskar B; Pratap Reddy P; Mukkanti K J Pharm Biomed Anal; 2006 Feb; 40(3):605-13. PubMed ID: 16324814 [TBL] [Abstract][Full Text] [Related]
12. Identification, isolation, synthesis and characterization of impurities of quetiapine fumarate. Bharathi Ch; Prabahar KJ; Prasad ChS; Srinivasa Rao M; Trinadhachary GN; Handa VK; Dandala R; Naidu A Pharmazie; 2008 Jan; 63(1):14-9. PubMed ID: 18271296 [TBL] [Abstract][Full Text] [Related]
13. Characterization of Five Oxidative Degradation Impurities and One Process Impurity of Suvorexant Drug Substance by LC-MS/MS, HR-MS and 1D, 2D NMR: Validation of Suvorexant Drug Substance and Process Impurities by HPLC and UPLC. Rajana N; Devi DR; Kumar Reddy DN; Babu JM; Basavaiah K; Balakumaran K J Chromatogr Sci; 2020 Apr; 58(5):433-444. PubMed ID: 32134104 [TBL] [Abstract][Full Text] [Related]
14. Isolation and Characterization of an Unknown Process-Related Impurity in Furosemide and Validation of a New HPLC Method. Xu A; Xue Y; Zeng Y; Li J; Zhou H; Wang Z; Chen Y; Chen H; Jin J; Zhuang T Molecules; 2023 Mar; 28(5):. PubMed ID: 36903659 [TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of a principal oxidation impurity in clopidogrel drug substance and drug product. Mohan A; Hariharan M; Vikraman E; Subbaiah G; Venkataraman BR; Saravanan D J Pharm Biomed Anal; 2008 May; 47(1):183-9. PubMed ID: 18313249 [TBL] [Abstract][Full Text] [Related]
16. HPLC analysis, semi-preparative HPLC preparation and identification of three impurities in salidroside bulk drug. Peng Y; Luo J; Lu Q; Chen X; Xie Y; Chen L; Yang W; Du S J Pharm Biomed Anal; 2009 Apr; 49(3):828-32. PubMed ID: 19167183 [TBL] [Abstract][Full Text] [Related]
18. Isolation, identification and characterization of two novel process-related impurities in olanzapine. Zhuang T; Zhang W; Cao L; He K; Wang Y; Li J; Chen L; Liu B; Zhang G J Pharm Biomed Anal; 2018 Apr; 152():188-196. PubMed ID: 29414012 [TBL] [Abstract][Full Text] [Related]
19. Characterization of two unknown impurities in roxithromycin by 2D LC-QTOF/MS/MS and NMR. Wang J; Zhou J; Xu Y; Zhu B; Jin Y J Pharm Biomed Anal; 2020 May; 184():113196. PubMed ID: 32113121 [TBL] [Abstract][Full Text] [Related]